Enveric Biosciences (ENVB) EBT Margin (2014 - 2025)
Enveric Biosciences' EBT Margin was -11.66% in Q3 2020, down 12.10 percentage points from 0.44% a year earlier but up 7.19 percentage points from the prior quarter.
Powered by 
Analysis
Enveric Biosciences (ENVB) EBT Margin (2014 - 2025) Analysis & Trends
On a trailing twelve-month basis, Enveric Biosciences' EBT Margin was -18.18% through Sep 30, 2020, up 22.01 percentage points year-over-year; for FY2019, it came in at -13.08%, up 11.46 percentage points from FY2018.
- EBT Margin shows a four-year change of -7.98 percentage points (FY2015 to FY2019).
- In earlier years, EBT Margin was -24.53% in FY2018 (-0.94 pp), -23.60% in FY2017 (-5.54 pp), -18.05% in FY2016 (-12.96 pp) and -5.10% in FY2015.
- Quarterly EBT Margin has moved between -130.71% (Q4 2018) and 54.13% (Q3 2018) over five years.
- Compared with a year earlier, EBT Margin has declined for three straight quarters, with an average year-over-year change of -8.88 percentage points over the last eight quarters.
- The best year-over-year quarter for EBT Margin over five years was Q4 2019 (a gain of 107.23 percentage points); the worst was Q4 2018 (a drop of 100.89 percentage points).
- Per Business Quant data, ENVB's EBT Margin in the three quarters before Q3 2020 was -18.85% (Q2 2020), -18.36% (Q1 2020) and -23.48% (Q4 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -4.34% |
| 10 | Enveric Biosciences | 6.02 Mn | -15.62 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -683,820.80% |
| Mar 31, 2025 | -67,188.38% |
| Jun 30, 2024 | -3,616.65% |
| Mar 31, 2024 | -5,314.71% |
| Dec 31, 2023 | -603,112.72% |
| Sep 30, 2023 | -125,865.94% |
| Jun 30, 2023 | -693,892.25% |
| Sep 30, 2020 | -11.66% |
| Jun 30, 2020 | -18.85% |
| Mar 31, 2020 | -18.36% |
| Dec 31, 2019 | -23.48% |
| Sep 30, 2019 | 0.44% |
| Jun 30, 2019 | -11.26% |
| Mar 31, 2019 | -17.70% |
| Dec 31, 2018 | -130.71% |
| Sep 30, 2018 | 54.13% |
| Jun 30, 2018 | -11.38% |
| Mar 31, 2018 | -14.21% |
| Dec 31, 2017 | -29.82% |
| Sep 30, 2017 | -32.41% |
API Access
Enveric Biosciences EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();